Anti-GLP-1 (central) Antibody (21)
Our mouse GLP-1 (central) monoclonal antibody from Antibodies Incorporated is produced in-house from clone 21. It detects human GLP-1 (central) and is Protein A or Protein G purified. Works in ELISA.
SKU: ABS 046-21-010
Ships: 1-2 business days
Product Details
GLP-1 (central)
GLP-1 is a peptide hormone of the glucagon family, produced by the L cells of the intestinal mucosa from the same prohormone as glucagon. The active forms are potent stimulators of glucose-dependent insulin secretion. The sequence of GLP-1 is fully conserved in all mammalian species examined so far.
Protein A or Protein G purified
1 mg/mL ±15%
Monoclonal
21
IgG1/k
ELISA
Mouse
GCG
20 kDa (proglucagon)
Synthetic GLP-1(9-37)
Human
Human
2-8°C without exposure to light
Liquid
BSA free
0.01 M phosphate buffer, pH 7.4, with 0.5 M NaCl and 15 mM sodium azide
ABS 046-21 is suitable for detection of GLP-1(7-37), GLP-1(9-36) and GLP-1(9-37) with indirect ELISA. The recommended starting concentration for testing is 1 µg/ml. ABS 046-21 (as capture antibody) forms a sandwich ELISA antibody pair with ABS 046-03B (as biotinylated detection antibody) for measuring GLP-1(7-37) and GLP-1(9-37). The recommended coating concentration for ABS 046-21 as capture antibody is 2 µg/ml when used in combination with ABS 046-03B at a concentration of 0.1 µg/ml.
Unconjugated
ABS 046-21 binds the mid-region of GLP-1(7-37), GLP-1(9-36) and GLP-1(9-37)
These antibodies are to be used as research laboratory reagents and are not for use as diagnostic or therapeutic reagents in humans.
United States
24 months from date of receipt
GCG; Pro-glucagon; Cleaved into: Glicentin; Glicentin-related polypeptide; GRPP; Oxyntomodulin; OXM; OXY; Glucagon; Glucagon-like peptide 1; GLP-1; Incretin hormone; Glucagon-like peptide 1(7-37; GLP-1(7-37; Glucagon-like peptide 1(7-36; GLP-1(7-36; Glucagon-like peptide 2; GLP-2; GLP1; GLP2; incretin; preproglucagon
[Glucagon]: Plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes. Binds to and activates the glucagon receptor GCGR, which couples to the G(s) G protein and elevates intracellular cAMP, triggering downstream metabolic responses (PubMed:32193322). {ECO:0000269|PubMed:32193322, ECO:0000303|PubMed:10605628, ECO:0000303|PubMed:12626323}.; [Glucagon-like peptide 1]: Potent stimulator of glucose-dependent insulin release (PubMed:22037645, PubMed:40446798). Also stimulates insulin release in response to IL6 (PubMed:22037645). Plays important roles on gastric motility and the suppression of plasma glucagon levels (PubMed:10605628, PubMed:14719035, PubMed:12554744). May be involved in the suppression of satiety and stimulation of glucose disposal in peripheral tissues, independent of the actions of insulin (PubMed:10605628, PubMed:14719035, PubMed:12554744). Has growth-promoting activities on intestinal epithelium (PubMed:10605628, PubMed:14719035, PubMed:12554744). May also regulate the hypothalamic pituitary axis (HPA) via effects on LH, TSH, CRH, oxytocin, and vasopressin secretion (PubMed:10605628, PubMed:14719035, PubMed:12554744). Increases islet mass through stimulation of islet neogenesis and pancreatic beta cell proliferation (PubMed:10605628, PubMed:14719035, PubMed:12554744). Inhibits beta cell apoptosis (PubMed:10605628, PubMed:14719035, PubMed:12554744). {ECO:0000269|PubMed:22037645, ECO:0000269|PubMed:40446798, ECO:0000303|PubMed:10605628, ECO:0000303|PubMed:12554744, ECO:0000303|PubMed:14719035}.; [Glucagon-like peptide 2]: Stimulates intestinal growth and up-regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. The gastrointestinal tract, from the stomach to the colon is the principal target for GLP-2 action. Plays a key role in nutrient homeostasis, enhancing nutrient assimilation through enhanced gastrointestinal function, as well as increasing nutrient disposal. Stimulates intestinal glucose transport and decreases mucosal permeability. {ECO:0000303|PubMed:10322410, ECO:0000303|PubMed:10605628, ECO:0000303|PubMed:12554744, ECO:0000303|PubMed:14719035}.; [Oxyntomodulin]: Significantly reduces food intake. Inhibits gastric emptying in humans. Suppression of gastric emptying may lead to increased gastric distension, which may contribute to satiety by causing a sensation of fullness. {ECO:0000303|PubMed:10605628, ECO:0000303|PubMed:12554744}.; [Glicentin]: May modulate gastric acid secretion and the gastro-pyloro-duodenal activity. May play an important role in intestinal mucosal growth in the early period of life. {ECO:0000303|PubMed:10605628, ECO:0000303|PubMed:12554744}.
2641
Shipped on ice packs

